NEWARK, Del, March 21, 2023 (GLOBE NEWSWIRE) -- The Endometrial Ablation Market revenues were estimated at US$ 3.4 Billion in 2023 and is anticipated to grow at a CAGR of 7.3% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 6.8 Billion. The aggregate revenue from US and China was US$ 1.4 Billion in 2022.
With the advent of minimally invasive endometrial ablation treatments, the endometrium can be destroyed in a more expedient, outpatient setting. This operation is less dangerous and technically straightforward to carry out.
For details on vendors and their offerings – Request a sample report
The International Federation of Gynaecology and Obstetrics estimates that between 3% and 30% of reproductive-aged women are affected by ABillionormal Uterine Bleeding. Women's treatment plans have become the key focus of the general health industry in the modern world. Governments and private organizations around the world have placed women's health at the center of their wellbeing race.
In India, such as in many other locations, women are eligible for several tax benefits and exemptions under the provisions of several sections of the tax code. Women's healthcare initiatives may promote the effectiveness of treatment alternatives, which will boost the market.
Key players:
- Medtronic
- CooperSurgical Inc.
- Boston Scientific Corp.
- Ethicon, Inc.
- Olympus Corp.
- Richard Wolf GmbH
- AngioDynamics
- Hologic, Inc.
- Minerva Surgical, Inc.
Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-16577
A few of the recent developments in the market are:
- In February 2021, CooperSurgical, a division of CooperCompanies, acquired Aegea Medical, nearly a year after the company received FDA approval for its Mara water vapor ablation system for severe menstrual bleeding.
- In May 2019, Medtronic Plc announced a partnership with Koninklijke Philips N.V. This collaboration is projected to result in an integrated cryoablation solution that is cutting-edge in terms of image guidance.
- In April 2021, Olympus Corporation relocated its Therapeutic Solutions Division's worldwide headquarters from Tokyo to the United States in order to gain better access to the medical industry and earn more revenue through expanded commercial prospects.
- In June 2021, Boston Scientific purchased the remaining shares of FARAPULSE. Boston Scientific's electrophysiology sector was bolstered by the acquisition, which added pulsed-field ablation technology to the company's offerings.
Market Segments Covered in Endometrial Ablation Market Analysis
By Type:
- Devices
- Cryoablation
- Radiofrequency Ablation
- Hydrothermal Ablation
- Thermal Balloon
- Microwave Energy
- Procedures
By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
Grow your profit margin with FutureMarketInsights – Buy the report!
Table of Content
1. Executive Summary | Endometrial Ablation Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Future Market Insights Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
Complete TOC with Report Preview: https://www.futuremarketinsights.com/reports/endometrial-ablation-market
Have a Look at Related Research Reports in the Healthcare Domain:
Adrenal Crisis Management Market Size - The global adrenal crisis management market garnered a market value of US$ 3.3 million in 2022 and is expected to accumulate a market value of US$ 6.31 million by registering a CAGR of 6.7% in the forecast period 2023 to 2033.
Severe Hypertriglyceridemia (SHTG) Treatment Market Share - The global severe hypertriglyceridemia (SHTG) treatment market garnered a market value of US$ 615 Million in 2022 and is expected to accumulate a market value of US$ 2675.37 Million by registering a CAGR of 14.3% in the forecast period 2023-2033.
Stuttering Therapeutics Market Growth - The global Stuttering Therapeutics Market is expected to garner a market value of US$ 43 Million in 2023 and is expected to accumulate a market value of US$ 159.41 Million by registering a CAGR of 14% in the forecast period 2023 to 2033.
Radiotherapy Induced Oral Mucositis Treatment Market Trends - The global Radiotherapy Induced Oral Mucositis Treatment Market is expected to garner a market value of US$ 3 Billion in 2023 and is expected to accumulate a market value of US$ 4.89 Billion by registering a CAGR of 5% in the forecast period 2023 to 2033.
Secondary Myelofibrosis Therapeutics Market Demand - The global secondary myelofibrosis therapeutics market garnered a market value of US$ 1.4 Million in 2022 and is expected to accumulate a market value of US$ 2.74 Million by registering a CAGR of 6.3% in the forecast period 2023 to 2033.
About Future Market Insights, Inc.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S., and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
